Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E D Maguire

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Thrombosis Research|October 1, 1983
In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the ratE D Maguire, R B Wallis
British Journal of Pharmacology|February 1, 1977
The role of bacterial contamination in the isolation of apparent anti-inflammatory factors from rabbit anti-lymphocytic serumE D Maguire, R B Wallis
Biochemical Society Transactions|December 1, 1980
Purification of a heparin-neutralizing protein from guinea-pig platelets and its comparison with human platelet factor 4E D Maguire, R B Wallis
Advances in Experimental Medicine and Biology|January 1, 1985
Role of thromboxane A2J Ambler, J Birch, E D Maguire, et al.
Thrombosis Research|February 1, 1981
Prolonged inhibition of ex vivo sodium arachidonate-induced platelet aggregation and malondialdehyde (MDA) production by sulphinpyrazone (Anturan) in manE D Maguire, G F Pay, R B Wallis, et al.
British Journal of Pharmacology|October 1, 1985
CGS 12970: a novel, long acting thromboxane synthetase inhibitorJ Ambler, K D Butler, E C Ku, et al.
Thrombosis and Haemostasis|February 26, 1982
Prolongation of rat tail bleeding time caused by oral doses of a thromboxane synthetase inhibitor which have little effect on platelet aggregationK D Butler, E D Maguire, J R Smith, et al.
Haemostasis|January 1, 1981
The effects of two different dosage regimens of sulphinpyrazone on platelet function ex vivo and blood chemistry in manE D Maguire, G F Pay, J Turney, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Thrombosis Research|October 1, 1983
In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the ratE D Maguire, R B Wallis
British Journal of Pharmacology|February 1, 1977
The role of bacterial contamination in the isolation of apparent anti-inflammatory factors from rabbit anti-lymphocytic serumE D Maguire, R B Wallis
Biochemical Society Transactions|December 1, 1980
Purification of a heparin-neutralizing protein from guinea-pig platelets and its comparison with human platelet factor 4E D Maguire, R B Wallis
Advances in Experimental Medicine and Biology|January 1, 1985
Role of thromboxane A2J Ambler, J Birch, E D Maguire, et al.
Thrombosis Research|February 1, 1981
Prolonged inhibition of ex vivo sodium arachidonate-induced platelet aggregation and malondialdehyde (MDA) production by sulphinpyrazone (Anturan) in manE D Maguire, G F Pay, R B Wallis, et al.
British Journal of Pharmacology|October 1, 1985
CGS 12970: a novel, long acting thromboxane synthetase inhibitorJ Ambler, K D Butler, E C Ku, et al.
Thrombosis and Haemostasis|February 26, 1982
Prolongation of rat tail bleeding time caused by oral doses of a thromboxane synthetase inhibitor which have little effect on platelet aggregationK D Butler, E D Maguire, J R Smith, et al.
Haemostasis|January 1, 1981
The effects of two different dosage regimens of sulphinpyrazone on platelet function ex vivo and blood chemistry in manE D Maguire, G F Pay, J Turney, et al.
Pageof 1